Navigation Links
Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Date:1/13/2009

LA JOLLA, Calif., Jan. 13 /PRNewswire/ -- Burnham Institute for Medical Research (Burnham) has signed an assay development and license agreement with Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD). The agreement is Burnham's first broad-based partnership with a large pharmaceutical company.

Under this multi-year agreement, Burnham will provide J&JPRD with access to high-throughput assay screening technologies to investigate certain drug targets for inflammatory diseases. Financial terms were not disclosed.

"This collaboration offers great synergies," said Dr. John Reed, Burnham President and CEO, Professor and Donald Bren Presidential Chair. "Burnham has great expertise in finding new targets and screening compounds to identify chemical leads, and I believe this collaboration will foster the discovery of drug products with real clinical potential."

About Burnham Institute for Medical Research

Burnham Institute for Medical Research is dedicated to revealing the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Burnham, with operations in California and Florida, is one of the fastest growing research institutes in the country. The Institute ranks among the top four institutions nationally for NIH grant funding and among the top 25 organizations worldwide for its research impact. Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, infectious and inflammatory and childhood diseases. The Institute is known for its world-class capabilities in stem cell research and drug discovery technologies.

In September 2008, Burnham was awarded a prestigious six-year, $98 million Molecular Libraries Probe Production Centers Network (MLPCN) grant from the National Institutes of Health, and is one of four com
'/>"/>

SOURCE Burnham Institute for Medical Research
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology
2. Cyntellect to Collaborate With the Burnham Institute for Medical Research
3. Oncolytics Biotech Inc. Announces Issuance of 31st U.S. Patent
4. Neurobiological Technologies Announces Suspension of Viprinex Development
5. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
6. Datafarm, Inc., Announces the Appointment of Daniel F. Orfe to Vice President, Global Regulatory Submission Services
7. Varian, Inc. Announces Online Experience
8. Victhom announces the completion of the second phase of the apnea therapy development
9. The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates
10. Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium
11. Abbott Announces Earnings Guidance for 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The FBI recently approved the Promega PowerPl...ing in or generating DNA records for the National ...on, WI USA (PRWEB) -- The FBI recently approved th... laboratories participating in, or generating DNA ... NDIS currently contains more than seven million p...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASD...pany,today,announcedthatithassubmittedaMAAtotheEur...ny,senzymereplacementtherapyindevelopment,forthetr...ng,applicationforvelaglucerasealfathathasbeensubmi...anada. , Basedonaglobalsupplyshortageofthecur...
(Date:11/24/2009)...ovember24/PRNewswire/--HealthRoboticstodayannounce...pofselected,investors.ThisrecentlyformedToronto-ba...nada,Inc.andwillmarket,install,andsupport,HealthRo...,revolutionaryproductofferingsi.v.STATION(TM),i.v....lsoprovideassistanceonan"asneeded,basis"toitsstrat...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--CellTherapeutics,Inc.(CTI...AnnualPiperJaffrayHealthCareConference.Theconferen...el. ,, CTIwillpresentonTuesday,December1at11:00...stofCTI,spresentationwillbeavailableat www.cellthe...terwards. , ,PiperJaffrayHealthCareConference,New...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
... African Ancestry Helps A-List Line Up...their Roots in Africa; RIse of consumer genetic te...n descent spawn trend in African Americans to trac...son. , Washington, DC (PR...t Barack Obama won,t have to grapple with in the O...
... Conn. Science fiction writers have long envision...e sun,s light. But, the forces of sunlight are too...een tried. Now a team led by researchers at the Y...hown that the force of light indeed can be harness...o nano-proportions. , Their work opens the door ...
... The new DNA Mini Portrait™ is t... New York, NY(PRWEB) November 26, 20... portraits made from the customers, DNA, launch DN... DNA Art that combines art, technology, beauty and... unique gifting solution for this holiday season t...
Other Biology Technology:Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama 2Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama 3'The photon force is with us': Harnessing light to drive nanomachines 2DNA 11, Creators of DNA Art, Introduces a More Affordable Line of Custom Portraits for this Year's Gift Giving Season 2
(Date:11/25/2009)... the Cell Death Research Laboratory in the Univers...rded the prestigious Johnson & Johnson Focused Fun... brain cell damage in Parkinson,s disease. The awa...pport of innovation and excellence in science, was...er this month at an event at the Hyatt Regency Hot...
(Date:11/25/2009)...e, the heart pumps some 250 million liters of bloo...uscle fibers of the heart have to be extremely dur...ttbauer, vice chair of the Department of Medicine ...rof. Dr. H. A. Katus), has discovered a protein th...t muscular unit, the sarcomere. In cooperation wit...
(Date:11/25/2009)...ay be just as vital to your health as what you eat...ogical Studies. Their experiments in mice revealed...genes in the liverthe body,s metabolic clearinghou...he body,s circadian clock as conventional wisdom h...ty of a large number of genes completely independe...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 1CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 2CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 1KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 4KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 5KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 6A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2
...optimize the cardiac function of patients with hea...atients might be at higher risk of dying suddenly ...ke University Medical Center. , Besides maintainin...se CRT-D (cardiac resynchronization therapy with d...new view of subtle changes in a key measurement of...
...f Liverpool have discovered how fish have evolved ... at different water depths. , A research team led...ist at the School of Biological Sciences, has reve...eveloped a way of floating at certain water levels...nvestigated the mechanism that allows fishes to ke...
...iversity scientists have "programmed" cells to mak...d high-resolution, deep-tissue imaging of gene exp... of Nature Medicine, hold considerable promise for...eld of molecular therapeutics and for monitoring t...or 20 years it has been the chemist,s job to devel...
Other Biology News:Implanted Devices Detect High-Risk Heart Failure Patients 2Implanted Devices Detect High-Risk Heart Failure Patients 3Scientists discover how fish evolved to float at different sea depths 2Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals 2
... value of your microarray data using Asuragens bio...ed from consultation to extensive data analysis us...tise in combination with the Gene Expression Profi...ts., ,Normalization and basic statistical anal...
CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich
... (OSM) is a pleiotropic cytokine produced by activ.... OSM inhibits the growth of some tumour and norma...and Kaposis sarcoma cell proliferation, cytokine r...protein receptor expression on hepatoma cells. Mou...
...syringe pump series combines Harvard Apparatuss be...ce and a wide range of configuration options. A lo...nsions of syringes from all the major manufacturer...e pertinent information from across the lab. All m...
Biology Products: